Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Misako Nagasaka

Dr. Misako Nagasaka

Medical Oncologist

Dr. Misako Nagasaka is a well-respected medical oncologist at the Barbara Ann Karmanos Cancer Institute in Detroit, where she treats thoracic malignancies such as lung cancer, esophageal cancer and pleural mesothelioma.

Get in touch
Jump to a Topic:

About Misako Nagasaka

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Pleural and Lung Cancer icon

    Pleural Mesothelioma

  • Immunotherapy icon


Get to Know Dr. Misako Nagasaka

Dr. Misako Nagasaka plays a key role in the multidisciplinary treatment of thoracic and head-and-neck malignancies at the Barbara Ann Karmanos Cancer Institute, specializing in molecular targeting and novel immunotherapy.

With an unusual background that includes philosophy and ethics, Nagasaka is known for an ability to put patients at ease, fully educating them on their treatment options with her personalized approach.

She has more than a decade of experience in treating lung cancer and mesothelioma patients, exploring options that go well beyond standard chemotherapy.

Nagasaka’s research involves novel clinical trials that have advanced the treatment of lung cancer with various immunotherapy combinations. She works closely with surgical oncologists, radiologists and pathologists at Karmanos to individualize treatment for each patient.

She also serves as an assistant professor of oncology at Wayne State University.

Specialties of Dr. Misako Nagasaka

Dr. Misako Nagasaka’s Experience and Medical Education

  • Barbara Ann Karmanos Cancer Institute
  • Beth Israel Medical Center in New York (Residency)
  • National Center for Global Health and Medicine, Tokyo (Residency)
  • Karmanos Cancer Institute (Hematology and oncology fellowships)
  • St. Marianna University School of Medicine, Japan

Awards and Other Recognitions

  • N Program Scholar Award, Tokio Marine Foundation
  • St. Marianna University Scholarship Award
  • American Society of Clinical Oncology (Member)
  • American College of Physicians (Member)
  • American Board of Internal Medicine (Member)
  • Mesothelioma Clinical Trials Under Misako Nagasaka M.D.
  • A phase II clinical trial studying the efficacy of using nintedanib (Ofev), an immunotherapy drug, for patients with recurrent pleural mesothelioma.

Publications of Dr. Misako Nagasaka

  • Nagasaka, M. et al. (2020, May 11). Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis. Proceedings of the National Academy of Sciences.
  • Nagasaka, M. et al. (2019, June 18). A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors. Dovepress.
  • Abdallah, N. et al. (2018, July 17). Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation. Dovepress.

Disclaimer: Dr. Misako Nagasaka has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Karmanos Cancer Institute. (n.d.). Misako Nagasaka, M.D. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 18, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now